Literature DB >> 4545188

A patient with nonketotic hyperglycinemia: biochemical findings and therapeutic approaches.

J M Trijbels, L A Monnens, S P van der Zee, J A Vrenken, R C Sengers, E D Schretlen.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1974        PMID： 4545188     DOI： 10.1203/00006450-197405000-00009

Source DB:  PubMed          Journal:  Pediatr Res        ISSN： 0031-3998            Impact factor:   3.756


× No keyword cloud information.
  6 in total

1.  Benzoate treatment and the glycine index in nonketotic hyperglycinaemia.

Authors:  J L K Van Hove; K Vande Kerckhove; J B Hennermann; V Mahieu; P Declercq; S Mertens; M De Becker; P S Kishnani; J Jaeken
Journal:  J Inherit Metab Dis       Date:  2005       Impact factor: 4.982

Review 2.  Non-ketotic hyperglycinaemia: clinical and biochemical aspects.

Authors:  K Tada; K Hayasaka
Journal:  Eur J Pediatr       Date:  1987-05       Impact factor: 3.183

3.  Evidence of lack of toxicity of sodium phenylacetate and sodium benzoate in treating urea cycle enzymopathies.

Authors:  M L Batshaw; S W Brusilow
Journal:  J Inherit Metab Dis       Date:  1981       Impact factor: 4.982

4.  Dextromethorphan in nonketotic hyperglycinaemia: metabolic variation confounds the dose-response relationship.

Authors:  G L Arnold; M L Griebel; J L Valentine; D M Koroma; G L Kearns
Journal:  J Inherit Metab Dis       Date:  1997-03       Impact factor: 4.982

5.  One-methyl group metabolism in non-ketotic hyperglycinaemia: mildly elevated cerebrospinal fluid homocysteine levels.

Authors:  J L Van Hove; F Lazeyras; S H Zeisel; T Bottiglieri; K Hyland; H C Charles; L Gray; J Jaeken; S G Kahler
Journal:  J Inherit Metab Dis       Date:  1998-12       Impact factor: 4.982

Review 6.  Single amino acid supplementation in aminoacidopathies: a systematic review.

Authors:  Danique van Vliet; Terry G J Derks; Margreet van Rijn; Martijn J de Groot; Anita MacDonald; M Rebecca Heiner-Fokkema; Francjan J van Spronsen
Journal:  Orphanet J Rare Dis       Date:  2014-01-13       Impact factor: 4.123
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.